Class information for:
Level 1: NEBIVOLOL//NEBIVOLOL HYDROCHLORIDE//THIRD GENERATION BETA BLOCKERS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
20336 465 34.7 74%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
522 3       MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM 20526
878 2             NEBIVOLOL//CARVEDILOL//BETA BLOCKERS 11463
20336 1                   NEBIVOLOL//NEBIVOLOL HYDROCHLORIDE//THIRD GENERATION BETA BLOCKERS 465

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEBIVOLOL authKW 8439550 46% 60% 213
2 NEBIVOLOL HYDROCHLORIDE authKW 469040 2% 71% 10
3 THIRD GENERATION BETA BLOCKERS authKW 328332 1% 100% 5
4 VASODILATING BETA BLOCKERS authKW 321761 2% 70% 7
5 DL NEBIVOLOL authKW 196999 1% 100% 3
6 ALTERED LEFT VENTRICULAR FUNCTION authKW 131333 0% 100% 2
7 BETA1 ADRENOCEPTOR BLOCKERS authKW 131333 0% 100% 2
8 D L ENANTIOMERS authKW 131333 0% 100% 2
9 ERECTILE DYSFUNCTION AND HYPERTENSIVE AGENTS authKW 131333 0% 100% 2
10 INT CLIN RD address 131333 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Peripheral Vascular Diseases 2671 23% 0% 105
2 Cardiac & Cardiovascular System 2120 27% 0% 126
3 Pharmacology & Pharmacy 2119 40% 0% 186
4 Physiology 27 4% 0% 17
5 Medicine, Research & Experimental 16 3% 0% 16
6 Medicine, General & Internal 13 4% 0% 20
7 Urology & Nephrology 10 2% 0% 10
8 Theater 6 0% 0% 1
9 Toxicology 6 2% 0% 9
10 Chemistry, Medicinal 4 2% 0% 8

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INT CLIN RD 131333 0% 100% 2
2 ATLANTA VASC FDN 87554 0% 67% 2
3 BIOMED SURG SCI MED D 87554 0% 67% 2
4 DIABET CARDIOVASC EXCELLENCE 73871 1% 38% 3
5 BIOL CLINSERV PHARMCOLU644 65666 0% 100% 1
6 CHAIR THER EUT CLIN PHARMACOL 65666 0% 100% 1
7 CLIN ANAL FOOD SCI TOXICOL 65666 0% 100% 1
8 CNRS GRP MECAN INGN CELLULAIRE TISSULAIRE 756 65666 0% 100% 1
9 ECPM STEREOCHIM ASSOC 65666 0% 100% 1
10 EXCELLENT CARDIOVASC DIS 65666 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PERFUSION 12876 2% 2% 8
2 RUSSIAN JOURNAL OF CARDIOLOGY 6847 2% 1% 7
3 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 5350 6% 0% 30
4 JOURNAL OF CLINICAL HYPERTENSION 4822 2% 1% 9
5 CARDIOVASCULAR THERAPY AND PREVENTION 3161 1% 1% 6
6 KARDIOLOGIYA 2885 4% 0% 17
7 CARDIOVASCULAR DRUGS AND THERAPY 2732 2% 0% 9
8 BLOOD PRESSURE 2428 1% 1% 6
9 JOURNAL OF HYPERTENSION 2180 4% 0% 18
10 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS 1785 1% 1% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 NEBIVOLOL 8439550 46% 60% 213 Search NEBIVOLOL Search NEBIVOLOL
2 NEBIVOLOL HYDROCHLORIDE 469040 2% 71% 10 Search NEBIVOLOL+HYDROCHLORIDE Search NEBIVOLOL+HYDROCHLORIDE
3 THIRD GENERATION BETA BLOCKERS 328332 1% 100% 5 Search THIRD+GENERATION+BETA+BLOCKERS Search THIRD+GENERATION+BETA+BLOCKERS
4 VASODILATING BETA BLOCKERS 321761 2% 70% 7 Search VASODILATING+BETA+BLOCKERS Search VASODILATING+BETA+BLOCKERS
5 DL NEBIVOLOL 196999 1% 100% 3 Search DL+NEBIVOLOL Search DL+NEBIVOLOL
6 ALTERED LEFT VENTRICULAR FUNCTION 131333 0% 100% 2 Search ALTERED+LEFT+VENTRICULAR+FUNCTION Search ALTERED+LEFT+VENTRICULAR+FUNCTION
7 BETA1 ADRENOCEPTOR BLOCKERS 131333 0% 100% 2 Search BETA1+ADRENOCEPTOR+BLOCKERS Search BETA1+ADRENOCEPTOR+BLOCKERS
8 D L ENANTIOMERS 131333 0% 100% 2 Search D+L+ENANTIOMERS Search D+L+ENANTIOMERS
9 ERECTILE DYSFUNCTION AND HYPERTENSIVE AGENTS 131333 0% 100% 2 Search ERECTILE+DYSFUNCTION+AND+HYPERTENSIVE+AGENTS Search ERECTILE+DYSFUNCTION+AND+HYPERTENSIVE+AGENTS
10 L NEBIVOLOL 131333 0% 100% 2 Search L+NEBIVOLOL Search L+NEBIVOLOL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DE BOER, RA , VOORS, AA , VAN VELDHUISEN, DJ , (2007) NEBIVOLOL: THIRD-GENERATION BETA-BLOCKADE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 8. ISSUE 10. P. 1539-1550 60 85% 13
2 IGNARRO, LJ , (2008) DIFFERENT PHARMACOLOGICAL PROPERTIES OF TWO ENANTIOMERS IN A UNIQUE BETA-BLOCKER, NEBIVOLOL.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 2. P. 115-134 52 85% 40
3 GAO, YS , VANHOUTTE, PM , (2012) NEBIVOLOL: AN ENDOTHELIUM-FRIENDLY SELECTIVE BETA 1-ADRENOCEPTOR BLOCKER.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 59. ISSUE 1. P. 16 -21 48 77% 13
4 MUNZEL, T , GORI, T , (2009) NEBIVOLOL THE SOMEWHAT-DIFFERENT BETA-ADRENERGIC RECEPTOR BLOCKER.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 54. ISSUE 16. P. 1491 -1499 46 66% 74
5 KUROEDOV, A , COSENTINO, F , LUSCHER, TF , (2004) PHARMACOLOGICAL MECHANISMS OF CLINICALLY FAVORABLE PROPERTIES OF A SELECTIVE BETA(1)-ADRENOCEPTOR ANTAGONIST, NEBIVOLOL.CARDIOVASCULAR DRUG REVIEWS. VOL. 22. ISSUE 3. P. 155-168 44 85% 36
6 GUPTA, S , WRIGHT, HM , (2008) NEBIVOLOL: A HIGHLY SELECTIVE BETA(1)-ADRENERGIC RECEPTOR BLOCKER THAT CAUSES VASODILATION BY INCREASING NITRIC OXIDE.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 3. P. 189-202 40 73% 39
7 QUANG, TT , ROZEC, B , AUDIGANE, L , GAUTHIER, C , (2009) INVESTIGATION OF THE DIFFERENT ADRENOCEPTOR TARGETS OF NEBIVOLOL ENANTIOMERS IN RAT THORACIC AORTA.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 156. ISSUE 4. P. 601 -608 32 89% 17
8 MOEN, MD , WAGSTAFF, AJ , (2006) NEBIVOLOL: A REVIEW OF ITS USE IN THE MANAGEMENT OF HYPERTENSION AND CHRONIC HEART FAILURE.DRUGS. VOL. 66. ISSUE 10. P. 1389 -1409 46 62% 27
9 PRISANT, LM , (2008) NEBIVOLOL: PHARMACOLOGIC PROFILE OF AN ULTRASELECTIVE, VASODILATORY BETA(1)-BLOCKER.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 48. ISSUE 2. P. 225-239 51 52% 23
10 KAMP, O , METRA, M , BUGATTI, S , BETTARI, L , DEI CAS, A , PETRINI, N , DEI CAS, L , (2010) NEBIVOLOL HAEMODYNAMIC EFFECTS AND CLINICAL SIGNIFICANCE OF COMBINED BETA-BLOCKADE AND NITRIC OXIDE RELEASE.DRUGS. VOL. 70. ISSUE 1. P. 41-56 38 55% 33

Classes with closest relation at Level 1


Rank Class id link
1 15971 CARVEDILOL//TJ0711 HYDROCHLORIDE//CARVEDILOL ENANTIOMERS
2 18382 HUMAN FOREARM VASCULATURE//CGP 48369//ENDOTHELIUM
3 20681 CELIPROLOL//PERINDOPRIL THERAPEUTIC USE//1 BETA ADRENERGIC RECEPTOR
4 30907 ABS SANTA COLOMA GRAMENET 6//ACID BASE EXCRETION//BETA2 ANDRENERGIC RECEPTOR GENE
5 8730 BETA3 ADRENOCEPTOR//BRL 37344//ATYPICAL BETA ADRENOCEPTORS
6 2021 BETA BLOCKERS//HEART FAILURE//CARVEDILOL
7 32714 ALPHA BETA ADRENOCEPTOR BLOCKADE//KMUP 1//ACHYRANTHES BIDENTATA POLYPEPTIDES
8 18641 MINICHAL//CONSULTATION IMPROVEMENT//2ND LINE CHOICE THERAPY
9 18811 BISOPROLOL//BISOPROLOL EFFICACY//INTRAVESICAL BCG INSTILLATION
10 29751 DIASTOLIC TIME//AMEZINIUMMETILSULFATE//CLINICAL TRIAL MRFIT

Go to start page